Target intelligence / Profile preview

Diazepam binding inhibitor pseudogene

Molecular classification
Other (specifically: pseudogene)
01

Overview

The diazepam binding inhibitor pseudogene (ENSG00000262471) is a nonfunctional DNA segment in the human genome that shares significant sequence similarity to the functional **diazepam binding inhibitor (DBI)** gene. As a pseudogene, it does not produce a functional protein product, does not serve as a therapeutic target, and has no established biological or pharmacological role. Pseudogenes like this commonly arise through gene duplication or retrotransposition events but lose their ability to encode a protein due to disabling mutations. Most pseudogenes do not contribute to cellular processes or disease, though rare cases exist where pseudogenes have regulatory effects; there is no current evidence to suggest this is the case for this specific pseudogene.

02

Biological functions

Other (no direct functional role; pseudogenes by definition do not have protein-coding or direct biological activity)
03

Disease associations

Other (not implicated in disease due to lack of function; most pseudogenes are considered genomic "junk DNA" but some can have regulatory roles, though that's not established for this one)

Beyond the preview

Go deeper on Diazepam binding inhibitor pseudogene.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Diazepam binding inhibitor pseudogene.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call